BRAF and melanoma: The treatment approach for patients with good performance status stage IV melanoma who are not surgical candidates should include an assessment of BRAF mutation status, history and physical examination, serum LDH, baseline laboratory evaluation and whole body imaging (see Table 1), and assessment of tempo of disease, tumor burden, and presence or absence of CNS disease before treatment selection.